Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
36 studies found for:    " February 05, 2012":" March 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
22 Completed Phase I/IIa Dose-escalation Clinical Study of VAC-3S
Condition: HIV-1 Infection
Interventions: Biological: VAC-3S;   Biological: Placebo
23 Completed Early Access to TMC114/r and Other AVT for Treatment-naive or Early Treatment Experienced in HIV-1 Patients
Condition: HIV-1
Intervention: Drug: TMC114/ritonavir
24 Unknown  Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
Conditions: To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT;   To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
Interventions: Radiation: Radiation therapy;   Other: Venepuncture
25 Completed Methadone Maintenance and HIV Prevention: A Window of Opportunity in China
Conditions: Capacity Building;   Drug Use;   HIV/AIDS
Intervention: Behavioral: MMT CARE
26 Not yet recruiting Testing and Linkage to Care for Injecting Drug Users in Kenya
Condition: HIV Infection
Intervention: Behavioral: Point of Care CD4 count and peer case management
27 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA009-00-VP;   Biological: Placebo vaccine
28 Completed An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulation (VF) of tenofovir 1% gel;   Drug: Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel;   Radiation: Radiolabeling of study drugs and semen
29 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Intervention: Biological: VRC-HIVADV014-00-VP Vaccine
30 Completed A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel;   Drug: Universal HEC Placebo Gel Formulation
31 Unknown  A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy
Conditions: Diabetic Neuropathy;   Chemotherapy Induced Neuropathy;   HIV Neuropathy;   Trauma Induced Neuropathy
Intervention: Drug: Neuron012703 (Medical Food)
32 Recruiting Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated
Condition: HIV-1
Interventions: Drug: EFV/FTC/TDF + Losartan;   Drug: EFV/FTC/TDF;   Drug: FTC/TDF + MK-0518;   Drug: FTC/TDF+MK-0518+Losartan
33 Completed
Has Results
Sevelamer for Reducing Endotoxemia and Immune Activation
Condition: HIV-1 Infection
Interventions: Drug: Sevelamer carbonate;   Device: Sevelamer carbonate
34 Completed
Has Results
Intervention to Retain HIV-positive Patients in Medical Care
Condition: Primary Care Appointment Keeping
Interventions: Behavioral: Enhanced contact plus behavioral skills;   Behavioral: Enhanced contact only;   Behavioral: Standard of Care
35 Active, not recruiting Project N-Liten- HIV Prevention for African American Women
Condition: Sexually Transmitted Diseases
Interventions: Behavioral: Horizons+General Health Promotion (GHP);   Behavioral: Horizons+Motivational Enhancement Therapy (GMET)
36 Active, not recruiting Operational Research for Cryptococcal Antigen Screening
Conditions: Cryptococcal Meningitis;   Cryptococcus Neoformans;   Cryptococcosis
Intervention: Drug: Fluconazole

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years